Sports Betting Addiction Lawsuit Sports betting addiction lawsuits are being investigated for college students and young adults who developed gambling problems after using apps like FanDuel and DraftKings, alleging that the platforms failed to warn about the addictive nature of their features and marketing practices.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Change Healthcare Lawsuit Lawyers are reviewing Change Healthcare class action lawsuits for individuals who had their personal information stolen due to the data breach.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
AngioDynamics Port Catheter Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Processed Food Lawsuit Lawsuits are being pursued against the food industry over their manufacturing and advertising of ultra-processed foods, which have caused a generation of children to face an increased risk of developing childhood diabetes and other chronic illnesses.
Actos Bladder Cancer Settlements to be Pushed Before Bellwether Trial in MDL February 26, 2015 Austin Kirk Add Your Comments The U.S. District Judge presiding over all federal Actos bladder cancer lawsuits will require the parties to discuss potential settlements in advance of a trial scheduled for next year, in which at least five different cases may be consolidated for trial before one jury. There are currently more than 4,000 product liability lawsuits pending against Takeda Pharmaceuticals and Eli Lilly, which all involve nearly identical allegations that the companies provided inadequate warnings about the risk of bladder cancer from Actos, a popular type 2 diabetes drug. Since December 2011, complaints filed throughout the federal court system have been centralized before U.S. District Judge Rebecca F. Doherty in the Western District of Louisiana, as part of an MDL, or Multi-District Litigation. Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION Learn More About Actos Lawsuit Side effects of Actos may increase the risk of bladder cancer. Lawsuits are pending nationwide. Learn More SEE IF YOU QUALIFY FOR COMPENSATION As part of the coordinated proceedings in the MDL, small groups of cases have been prepared for early trial dates, known as “bellwether” cases. The first federal Actos trial ended in a landmark $9 billion jury award last year, after evidence was presented that indicated the drug makers destroyed evidence about the link between Actos and bladder cancer. While Judge Doherty later reduced the punitive damage award in the case to $37 million, she indicated that the Supreme Court needs to update rules on what is considered excessive in order to effectively deter large corporations from engaging in the type of bad behavior exhibited by Takeda and Eli Lilly. As a second group of cases are being prepared for trial to begin in May 2016, Judge Doherty issued a scheduling order (PDF) on February 23, which outlines the process for identifying cases that will participate in this bellwether trial. Included in the schedule are several formal negotiation periods, where the parties will meet with a Special Master to discuss and explore potential Actos settlements. The parties met with Judge Doherty today for a status conference, at which time progress on the claims was discussed with the Court, according to an agenda (PDF) posted on Monday. Selection of Actos Cases for Trial According to the plan outlined by Judge Doherty, a consolidated trial involving approximately five cases originally filed in the Western District of Louisiana will go before one jury beginning on May 2, 2016. By early next month, the drug makers have been instructed to nominate a primary case for this first trial grouping, which can include any case filed in the Western District, so long as it involves significant exposure to Actos during the period between 2006 and 2011. Following the selection of a primary case, each side will nominate three additional cases to be added to the trial pool. Judge Doherty has outlined several important factors that the parties should consider when making their nominations, suggesting that, if it is possible, each group should include at least one smoker and one non-smoker, at least one person with a known genetic tendency toward bladder cancer and one individual without such known tendency, and at least one person with industrial exposure known to increase the risk of bladder cancer and one who has not had any such known exposure. Following the submission of the nominees, the parties have been ordered to meet with a Special Master to discuss formal settlement regarding the cases included in the first trial nomination pool. A magistrate judge will also be available for mediation on any one case, or group of cases where appropriate. By June 1, 2015, the Court will make a final designation of the cases that will be included in the May 2016 trial. As the parties continue to prepare for that trial, several additional periods of formal settlement negotiations have been ordered by the Court. While the outcome of this “bellwether” trial will not be binding on any other cases, the process is designed to help the parties gauge how juries may respond to certain evidence and testimony that is likely to be repeated throughout the Actos litigation. In addition to the federal trial last year, a number of individual cases have gone before state court juries throughout the country, with multi-million damage awards returned in many of the cases. Most recently, Takeda was hit with a $3.6 million damage award in a Pennsylvania case, including $1.3 million in punitive damages designed to punish the drug makers. Tags: Actos, Bladder Cancer, Diabetes, Diabetes Drug, Takeda Pharmaceuticals Image Credit: | More Actos Lawsuit Stories Actos Bladder Cancer Warnings Updated by FDA to Add New Study Data Reviewed December 13, 2016 Bladder Cancer Risk with Actos Highlighted in a New Study April 5, 2016 Actos Side Effects May Increase Risk of Bone Fractures, Weight Gain: Study March 1, 2016 0 Comments Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes No Post Comment I authorize the above comments be posted on this page Weekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings. Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermPhoneThis field is for validation purposes and should be left unchanged. Δ MORE TOP STORIES MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025) Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025) BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)
MDL Judge Orders Paraquat Lawsuit Settlement Update By June 11, 2025 (Posted: today) A federal judge has agreed to stay all case-specific discovery deadlines in Paraquat lawsuits, while the parties work to hammer out a settlement agreement to resolve thousands of claims. MORE ABOUT: PARAQUAT PARKINSON’S DISEASE LAWSUITSParaquat Settlement Reached for Parkinson’s Disease Lawsuits Filed in MDL (04/16/2025)Appeals Court Urged To Reinstate Paraquat Lawsuits Previously Set for Bellwether Trials (02/14/2025)Paraquat Lawsuits Over Parkinson’s Disease Risk Set for Trial in October 2025, April 2026 (01/29/2025)
Court Outlines Requirements for Depo-Provera Lawsuit Proof of Use, Type of Meningioma Tumor (Posted: yesterday) As new Depo-Provera lawsuits continue to be filed, the judge presiding over the litigation has established key criteria for establishing proof of Depo-Provera use and medical documentation confirming a meningioma diagnosis. MORE ABOUT: DEPO-PROVERA LAWSUITDepo Shot Lawsuit Filed Over Serious Brain Tumor Injuries (05/07/2025)Lawsuit Alleges Depo-Provera Migraines, Headaches Led to Meningioma Brain Tumor Diagnosis (05/01/2025)Depo-Provera Hearing Loss Lawsuit Filed Over Brain Tumor Side Effects (04/22/2025)
BioZorb Implant Lawsuit Alleges Tissue Marker Caused Swelling, Fluid Buildup and Chronic Pain (Posted: 2 days ago) A Massachusetts woman’s injuries from a failed tissue marker that was recently recalled led to the need for physical therapy, according to a BioZorb implant lawsuit. MORE ABOUT: BIOZORB LAWSUITFour Women File BioZorb Lawsuit Over Breast Tissue Marker Failures and Injuries (05/05/2025)Lawsuit Claims BioZorb Marker Caused Chronic Pain, Multiple Surgeries After Lumpectomy (04/14/2025)Four BioZorb Breast Tissue Marker Lawsuits Selected for Bellwether Trials (04/02/2025)